ELGOZON 150MG Tablet contains Elagolix 150mg, a prescription hormonal medicine belonging to the gonadotropin-releasing hormone (GnRH) receptor antagonist class. Elagolix works by reducing the hormonal signals that stimulate ovarian estrogen production.
Elagolix may be prescribed for the management of endometriosis-associated pain and other approved gynecological conditions, depending on the specific product labeling and medical assessment. By lowering estrogen levels, ELGOZON may help reduce hormonal stimulation of endometrial tissue and relieve symptoms associated with endometriosis.
Because Elagolix can affect reproductive hormones, menstrual bleeding, bone mineral density, liver function, and fertility, ELGOZON 150MG should be used only under the supervision of a qualified healthcare professional.
ELGOZON 150MG Tablet is supplied by Horizon Pharma according to the provided product information.
Elagolix may help reduce pain associated with endometriosis by lowering ovarian estrogen activity.
ELGOZON decreases hormonal stimulation of the ovaries, resulting in reduced circulating estrogen levels.
Elagolix blocks GnRH receptors in the pituitary gland, reducing the release of LH and FSH and consequently reducing ovarian hormone stimulation.
Lower estrogen levels can reduce stimulation of endometrial tissue and may help improve endometriosis-related symptoms.
ELGOZON 150MG provides a convenient oral dosage form when Elagolix treatment is prescribed.
The appropriate dose and duration should be selected by a healthcare professional based on the patient's condition, liver function, treatment goals, and risk factors.
ELGOZON 150MG Tablet is listed under Horizon Pharma according to the supplied product details.
ELGOZON contains Elagolix, a GnRH receptor antagonist.
Normally, GnRH stimulates the pituitary gland to release LH (luteinizing hormone) and FSH (follicle-stimulating hormone). These hormones stimulate the ovaries and contribute to estrogen production.
Elagolix blocks GnRH receptors in the pituitary gland. This reduces LH and FSH stimulation of the ovaries and lowers estrogen levels.
Reduced estrogen exposure can decrease stimulation of endometrial tissue and may help relieve endometriosis-associated pain.
The extent of hormone suppression depends on the prescribed Elagolix dose.
Elagolix may be prescribed for approved gynecological conditions such as:
The 150mg strength may be used according to the prescribed treatment regimen and the patient's individual medical requirements.
Always use ELGOZON according to the instructions provided by your gynecologist or healthcare professional.
ELGOZON may be considered for adult women who:
Elagolix is not suitable for everyone. Your healthcare provider may consider:
| Active Ingredient | Strength | Function |
|---|---|---|
| Elagolix | 150mg | GnRH receptor antagonist that reduces ovarian hormonal stimulation and estrogen production |
Take ELGOZON exactly as prescribed by your doctor.
General administration guidance includes:
The appropriate Elagolix regimen depends on the medical indication, liver function, other medicines, and individual patient factors.
Do not self-adjust the dose.
Elagolix treatment is generally subject to duration limitations because prolonged estrogen suppression can reduce bone mineral density.
The recommended treatment duration depends on the strength, indication, and individual risk factors.
Your healthcare provider will determine how long you should continue ELGOZON and whether monitoring is required during treatment.
If you miss a dose, follow the missed-dose instructions provided by your doctor or the product information.
Do not take two tablets together to compensate for a missed dose unless specifically instructed by your healthcare professional.
Like all medicines, ELGOZON 150MG may cause side effects, although not everyone experiences them.
The frequency and severity of side effects may vary between individuals.
Elagolix lowers estrogen levels, which can result in a reduction in bone mineral density.
Patients with osteoporosis or other fracture risk factors may require additional assessment before treatment.
Contact your healthcare provider promptly if you develop concerning or persistent symptoms.
Before taking ELGOZON 150MG, tell your doctor if you:
Your healthcare provider may evaluate liver function, bone-health risk, and other factors before and during treatment.
Elagolix may affect liver enzymes in some patients.
Tell your doctor if you have liver disease or previous abnormal liver tests. Depending on liver function, Elagolix may require dose adjustment or may not be appropriate.
Seek medical advice if you develop possible symptoms of liver problems, including:
Estrogen is important for maintaining healthy bones.
Because ELGOZON reduces estrogen levels, prolonged treatment may decrease bone mineral density. This may be especially important for women who already have osteoporosis or other fracture risk factors.
Tell your healthcare provider if you have:
Your doctor will determine whether ELGOZON is suitable and whether bone-health monitoring is needed.
ELGOZON may change menstrual bleeding. Some women may experience lighter, irregular, or absent periods during treatment.
These changes can make pregnancy more difficult to recognize based only on menstrual patterns.
Elagolix can reduce ovulation but should not be relied upon as contraception.
If pregnancy is not desired, discuss appropriate contraceptive options with your healthcare provider.
Tell your doctor or pharmacist about all medicines and supplements you use.
Potentially important interactions may involve:
Some medicines can alter Elagolix exposure and may affect its safety or effectiveness.
Do not start, stop, or change another medicine without professional medical advice.
ELGOZON should not be used during pregnancy.
Elagolix affects reproductive hormones and may alter menstrual bleeding, potentially making pregnancy more difficult to recognize.
If you become pregnant while taking ELGOZON, contact your healthcare provider promptly.
If you are breastfeeding or planning to breastfeed, discuss Elagolix treatment with your doctor before use.
ELGOZON may cause dizziness, sleep disturbances, mood changes, or other symptoms in some patients.
If you experience dizziness or any effect that affects alertness or concentration, use caution when driving or operating machinery.
Contains Elagolix 150mg, a GnRH receptor antagonist used for approved hormone-dependent gynecological conditions.
Works by reducing GnRH-related hormonal signaling and ovarian estrogen production.
Provides a convenient oral treatment option when Elagolix therapy is prescribed.
Should be used following medical evaluation because Elagolix can affect bone health, liver function, menstrual bleeding, and reproductive hormones.
ELGOZON 150MG Tablet is listed under Horizon Pharma according to the supplied product information.
Sample/Placeholder Reviews – for demonstration only
⭐⭐⭐⭐⭐ Ayesha K. – Lahore
"SuperCare Pharma made the ordering process easy, and the medicine was delivered securely."
⭐⭐⭐⭐⭐ Sana M. – Karachi
"Convenient online ordering and the package arrived safely and properly packed."
⭐⭐⭐⭐⭐ Hira S. – Islamabad
"Good ordering experience with secure packaging and convenient delivery."
| Product Information | Details |
|---|---|
| Brand | HORIZON PHARMA |
| Product Name | ELGOZON 150MG TABLET |
| Generic | Elagolix |
| Strength | 150mg |
| Dosage Form | Tablet |
| Pack Size | 14 Tablets |
| Medicine Type | Prescription Medicine |
| Drug Class | GnRH Receptor Antagonist |
| Primary Use | Management of approved hormone-dependent gynecological conditions, including endometriosis-associated pain |
ELGOZON contains Elagolix 150mg and may be prescribed for the management of endometriosis-associated pain and other approved gynecological conditions.
Elagolix blocks GnRH receptors, reducing LH and FSH stimulation of the ovaries and lowering estrogen production.
Yes. Elagolix can change menstrual bleeding and may cause lighter, irregular, or absent periods during treatment.
Yes. Elagolix should not be considered reliable contraception. Discuss appropriate contraceptive options with your healthcare provider.
Elagolix can affect bone mineral density, liver function, mood, menstrual bleeding, and reproductive hormones. Your healthcare provider can determine the appropriate treatment duration and monitoring based on your individual risk factors.
Choose SuperCare Pharma for a convenient online pharmacy experience in Pakistan.
✔ Genuine pharmaceutical products
✔ Secure online ordering
✔ Convenient delivery across Pakistan
✔ Carefully packed orders
✔ Competitive pricing
✔ Customer support
ELGOZON 150MG is a prescription medicine. Use it only according to the advice of a qualified healthcare professional.
Looking for ELGOZON 150MG Tablet (Elagolix 150mg) in Pakistan? Order through SuperCare Pharma for a convenient online pharmacy experience and reliable delivery.
Because Elagolix is a prescription hormonal medicine with important precautions and treatment-duration considerations, use ELGOZON only according to your healthcare provider's instructions.
